The proposed settlement, filed late Wednesday in the U.S. District Court for the District of Kansas, would resolve class action claims brought against Pfizer on behalf of “end payers” like insurers, pension funds, and consumers that have targeted the two drug giants.
The deal doesn’t directly affect a parallel proposed class action moving ...